blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2696854

EP2696854 - FEBUXOSTAT SOLID DISPERSION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.03.2017
Database last updated on 24.07.2024
FormerRequest for examination was made
Status updated on  28.11.2016
Most recent event   Tooltip17.03.2017Change - prioritypublished on 19.04.2017  [2017/16]
Applicant(s)For all designated states
Ranbaxy Laboratories Limited
Head Office: 12th Floor Devika Tower 06 Nehru Place New Delhi
Delhi 110019 / IN
[2014/08]
Inventor(s)01 / KAUSHIK, Poonam
432/a Turab Nagar
Ghaziabad Uttar Pradesh 201001 / IN
02 / THAIMATTAM, Ram
3-5-545 Vittalwadi
Narayanguda
Hyderabad Andhra Pradesh 500029 / IN
03 / PRASAD, Mohan
D-50
Greenwoods City
Sector 46
Gurgaon Haryana 122003 / IN
 [2014/08]
Representative(s)Cronin, Brian Harold John, et al
CRONIN Intellectual Property Chemin de Précossy 31
1260 Nyon / CH
[2014/08]
Application number, filing date12722195.016.04.2012
WO2012IB51892
Priority number, dateIN2011DEL112015.04.2011         Original published format: IN 1120DE2011
[2017/16]
Former [2014/08]IN2011DEL112015.04.2011
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012140632
Date:18.10.2012
Language:EN
[2012/42]
Type: A1 Application with search report 
No.:EP2696854
Date:19.02.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 18.10.2012 takes the place of the publication of the European patent application.
[2014/08]
Search report(s)International search report - published on:EP18.10.2012
ClassificationIPC:A61K9/14, A61K31/426, A61K47/32
[2014/08]
CPC:
A61K31/426 (EP,US); A61K47/32 (US); A61K9/10 (US);
A61K9/146 (EP,US); A61K9/1635 (EP,US); B29B13/065 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/08]
TitleGerman:FESTE FEBUXOSTAT-DISPERSION[2014/08]
English:FEBUXOSTAT SOLID DISPERSION[2014/08]
French:DISPERSION SOLIDE DE FÉBUXOSTAT[2014/08]
Entry into regional phase15.11.2013National basic fee paid 
15.11.2013Designation fee(s) paid 
15.11.2013Examination fee paid 
Examination procedure15.11.2013Examination requested  [2014/08]
05.06.2014Amendment by applicant (claims and/or description)
01.11.2016Application deemed to be withdrawn, date of legal effect  [2017/14]
29.11.2016Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2017/14]
Fees paidRenewal fee
30.04.2014Renewal fee patent year 03
30.04.2015Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.04.201605   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]CN101780073  (CHONGQING SHENGHUAXI PHARMA CO) [X] 1-9 * second of preparation method; page 4 * * examples 15-17 * * claims 5-7 *;
 [Y]  - TIWARI R ET AL, "Solid dispersions: An overview to modify bioavailability of poorly water soluble drugs", INTERNATIONAL JOURNAL OF PHARMTECH RESEARCH, SHPINX KNOWLEDGE HOUSE, IN, (20091001), vol. 1, no. 4, ISSN 0974-4304, pages 1338 - 1349, XP009137553 [Y] 1-9 * Solvent method; page 1343, column r *
 [Y]  - DHIRENDRA K ET AL, "Solid dispersions: a review.", PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES APR 2009 LNKD- PUBMED:19339238, (200904), vol. 22, no. 2, ISSN 1011-601X, pages 234 - 246, XP002680094 [Y] 1-9 * page 237, column l, paragraph 3 - page 238, column l, paragraph 1 *
by applicantUS5614520
 US6225474
 US7541475
 US2009203919
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.